Teplizumab therapy for type 1 diabetes

Type 1 Diabetes TrialNet-An International Collaborative Clinical Trials Network

(2009) Jay S. Skyler et al.   Annals of the New York Academy of Sciences

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years

(2009) Kevan C. Herold et al.   CLINICAL IMMUNOLOGY

Progress towards the clinical use of CD3 monoclonal antibodies in the treatment of autoimmunity

(2009) Lucienne Chatenoud   Current Opinion in Organ Transplantation

Dendritic cell-based therapy in Type 1 diabetes mellitus

(2009) Brett Phillips et al.   Expert Review of Clinical Immunology

Immunotherapy of type 1 diabetes

(2008) Li Li et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Increased Expression of CCL2 in Insulin-Producing Cells of Transgenic Mice Promotes Mobilization of Myeloid Cells From the Bone Marrow, Marked Insulitis, and Diabetes

(2008) A. P. Martin et al.   DIABETES

Big Mac Attack: Does It Play a Direct Role for Monocytes/Macrophages in Type 1 Diabetes?

(2008) L.-J. Yang   DIABETES

GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes

(2008) Johnny Ludvigsson et al.   NEW ENGLAND JOURNAL OF MEDICINE